{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT02528903: Phase 1 Interventional Completed Healthy Volunteer
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00244257: Phase 1 Interventional Terminated Idiopathic Thrombocytopenic Purpura
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03512340: Phase 1 Interventional Completed Advanced Solid Cancers
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03362060: Phase 1 Interventional Active, not recruiting Triple Negative Breast Cancer
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03362060: Phase 1 Interventional Active, not recruiting Triple Negative Breast Cancer
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00001296: Phase 3 Interventional Completed Melanoma
(1992)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03456830: Phase 3 Interventional Completed Enteric Hyperoxaluria
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01222117: Phase 2 Interventional Completed Acute Peripheral Arterial Occlusion
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04655586: Phase 2/Phase 3 Interventional Completed Covid19
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02623322: Phase 2 Interventional Completed Influenza A
(2016)
Source URL:
Class:
PROTEIN
